Delayed
Swiss Exchange
11:31:59 2024-04-30 am EDT
|
5-day change
|
1st Jan Change
|
737
CHF
|
-0.14%
|
|
+5.06%
|
+8.22%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
14,887
|
19,951
|
23,880
|
14,642
|
15,928
|
17,238
|
-
|
-
|
Enterprise Value (EV)
1 |
14,655
|
19,818
|
23,789
|
14,406
|
15,696
|
16,860
|
16,809
|
16,734
|
P/E ratio
|
28.2
x
|
45.3
x
|
43.4
x
|
27.5
x
|
34.8
x
|
37.8
x
|
34.2
x
|
31.2
x
|
Yield
|
2.45%
|
1.52%
|
2.06%
|
3.19%
|
1.87%
|
2.37%
|
2.64%
|
2.85%
|
Capitalization / Revenue
|
6.91
x
|
11.1
x
|
10.6
x
|
6
x
|
7.28
x
|
7.77
x
|
7.26
x
|
6.84
x
|
EV / Revenue
|
6.81
x
|
11
x
|
10.6
x
|
5.9
x
|
7.17
x
|
7.6
x
|
7.07
x
|
6.64
x
|
EV / EBITDA
|
21.6
x
|
34.8
x
|
34.2
x
|
21.8
x
|
29
x
|
28.4
x
|
25.6
x
|
23.4
x
|
EV / FCF
|
30
x
|
46.8
x
|
54.3
x
|
53
x
|
29.8
x
|
41.5
x
|
37.2
x
|
33.8
x
|
FCF Yield
|
3.34%
|
2.14%
|
1.84%
|
1.89%
|
3.36%
|
2.41%
|
2.69%
|
2.96%
|
Price to Book
|
8.95
x
|
12.5
x
|
13.3
x
|
8.06
x
|
9.14
x
|
9.34
x
|
8.93
x
|
8.52
x
|
Nbr of stocks (in thousands)
|
23,389
|
23,389
|
23,389
|
23,389
|
23,389
|
23,389
|
-
|
-
|
Reference price
2 |
636.5
|
853.0
|
1,021
|
626.0
|
681.0
|
737.0
|
737.0
|
737.0
|
Announcement Date
|
2/7/20
|
2/12/21
|
2/11/22
|
2/10/23
|
2/9/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
2,153
|
1,802
|
2,254
|
2,442
|
2,189
|
2,220
|
2,376
|
2,521
|
EBITDA
1 |
677
|
569
|
696
|
661
|
542
|
592.9
|
656.5
|
714.1
|
EBIT
1 |
624
|
515
|
640
|
611
|
493
|
540
|
601.4
|
656.8
|
Operating Margin
|
28.98%
|
28.58%
|
28.39%
|
25.02%
|
22.52%
|
24.33%
|
25.31%
|
26.06%
|
Earnings before Tax (EBT)
1 |
621
|
519
|
641
|
607
|
492
|
547.6
|
599.7
|
661.6
|
Net income
1 |
532
|
440
|
550.3
|
535
|
461
|
460.8
|
504.6
|
553.4
|
Net margin
|
24.71%
|
24.42%
|
24.42%
|
21.91%
|
21.06%
|
20.76%
|
21.24%
|
21.95%
|
EPS
2 |
22.54
|
18.81
|
23.53
|
22.75
|
19.56
|
19.50
|
21.57
|
23.58
|
Free Cash Flow
1 |
489.2
|
423.2
|
438.4
|
271.9
|
527.1
|
405.9
|
451.9
|
495.2
|
FCF margin
|
22.72%
|
23.49%
|
19.45%
|
11.14%
|
24.08%
|
18.29%
|
19.02%
|
19.65%
|
FCF Conversion (EBITDA)
|
72.26%
|
74.38%
|
62.99%
|
41.14%
|
97.25%
|
68.47%
|
68.83%
|
69.34%
|
FCF Conversion (Net income)
|
91.95%
|
96.19%
|
79.66%
|
50.83%
|
114.33%
|
88.1%
|
89.55%
|
89.49%
|
Dividend per Share
2 |
15.60
|
13.00
|
21.00
|
20.00
|
12.75
|
17.50
|
19.43
|
21.00
|
Announcement Date
|
2/7/20
|
2/12/21
|
2/11/22
|
2/10/23
|
2/9/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019 S2
|
2020 S1
|
2020 S2
|
2021 S1
|
2021 Q3
|
2021 Q4
|
2021 S2
|
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2022 S2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 S2
|
---|
Net sales
1 |
996
|
849
|
953
|
1,166
|
525
|
563
|
1,088
|
638
|
646
|
1,284
|
587
|
571
|
1,158
|
1,183
|
514
|
492
|
546.6
|
562.4
|
1,110
|
1,083
|
EBITDA
|
331
|
256
|
315
|
349
|
-
|
-
|
347
|
-
|
-
|
354
|
-
|
-
|
307
|
306
|
-
|
-
|
-
|
-
|
269.5
|
288.7
|
EBIT
|
308
|
229
|
288
|
321
|
-
|
-
|
318
|
-
|
-
|
324
|
-
|
-
|
287
|
280
|
-
|
-
|
-
|
-
|
244.4
|
263.7
|
Operating Margin
|
30.92%
|
26.97%
|
30.22%
|
27.53%
|
-
|
-
|
29.23%
|
-
|
-
|
25.23%
|
-
|
-
|
24.78%
|
23.67%
|
-
|
-
|
-
|
-
|
22.03%
|
24.35%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
191
|
-
|
278
|
-
|
-
|
-
|
-
|
-
|
285
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
22.5%
|
-
|
23.84%
|
-
|
-
|
-
|
-
|
-
|
22.2%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
8.180
|
-
|
11.91
|
-
|
-
|
-
|
-
|
-
|
12.20
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
15.60
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/7/20
|
7/10/20
|
2/12/21
|
7/16/21
|
10/28/21
|
2/11/22
|
2/11/22
|
4/27/22
|
7/15/22
|
7/15/22
|
10/25/22
|
2/10/23
|
2/10/23
|
7/14/23
|
10/31/23
|
2/9/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
232
|
133
|
91.2
|
235
|
232
|
378
|
429
|
504
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
489
|
423
|
438
|
272
|
527
|
406
|
452
|
495
|
ROE (net income / shareholders' equity)
|
31.7%
|
27.2%
|
30.6%
|
29.3%
|
26.3%
|
26.2%
|
28.3%
|
28.4%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
71.10
|
68.30
|
76.90
|
77.60
|
74.50
|
78.90
|
82.60
|
86.50
|
Cash Flow per Share
2 |
23.60
|
20.20
|
22.20
|
15.60
|
24.70
|
26.70
|
26.60
|
30.20
|
Capex
1 |
62.9
|
48.3
|
79.9
|
94
|
49.4
|
56
|
61.9
|
79.4
|
Capex / Sales
|
2.92%
|
2.68%
|
3.55%
|
3.85%
|
2.26%
|
2.52%
|
2.61%
|
3.15%
|
Announcement Date
|
2/7/20
|
2/12/21
|
2/11/22
|
2/10/23
|
2/9/24
|
-
|
-
|
-
|
Average target price
664.3
CHF Spread / Average Target -9.87% Consensus |
1st Jan change
|
Capi.
|
---|
| +8.22% | 18.8B | | +14.02% | 64.66B | | -3.80% | 46.08B | | +13.26% | 39.72B | | +19.28% | 25.82B | | -1.13% | 17.14B | | -21.03% | 15.86B | | +1.06% | 15.05B | | -16.73% | 14.14B | | -24.13% | 13.05B |
Other Specialty Chemicals
|